ReviewAAPS PharmSciTech2026
AI-enabled, QbD-aligned Predictive, and Sustainable Design of Natural Polymer-based Drug Delivery Systems.
Review in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Renewable Feedstock Nanocarriers for Drug Delivery: Evidence Mapping and Translational Readiness.Pharmaceutics · 2026Review
- Formulation-Driven Innovation in Antifungal Therapy: From Nanotechnology to AI-Assisted Design.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural polymers such as chitosan, alginate, cellulose, gelatin, and silk fibroin have become central to modern drug delivery research due to their biocompatibility, biodegradability, and environmental sustainability. However, variability in source, molecular weight, and crosslinking chemistry often results in inconsistent formulation performance and limited scalability. To overcome these challenges, artificial intelligence (AI) and machine learning frameworks have been increasingly integrated into formulation science under the quality by design paradigm. This review synthesizes current advances in AI-assisted modeling and optimization of natural polymer drug delivery systems, highlighting how predictive algorithms capture nonlinear relationships among polymer structure, process variables, and release kinetics. Neural-network and Bayesian-optimization models demonstrate accurate prediction of encapsulation efficiency and dissolution profiles, while hybrid mechanistic-AI and physics-informed neural networks enhance interpretability by embedding kinetic and diffusion equations. The review also discusses data-generation workflows, FAIR-compliant standards, and polymer-informatics databases that enable interoperable, reproducible modeling. Collectively, these developments establish a pathway toward data-driven, sustainable pharmaceutics, where predictive and eco-designed formulations replace empirical trial-and-error methods. Remaining challenges include dataset standardization, model transparency, and regulatory validation. Addressing these will accelerate the translation of intelligent polymer design into reproducible, scalable, and environmentally responsible drug delivery innovations.
Indexed as
Identifiers
41612042What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.